文献速递耳科与耳神经鼻科咽喉与嗓音

COVID-19疫苗接种后的耳鼻咽喉科副作用

Otolaryngologic Side Effects After COVID-19 Vaccination.
PubMed 文献 · Laryngoscope · 2023-08-04

该研究基于美国食品药品监督管理局疫苗不良事件报告系统(VAERS)2020年12月至2021年5月的数据,回顾性分析COVID-19疫苗接种后耳鼻咽喉科不良事件的发生频率,并与其它疫苗比较。共报告1,280,950例不良事件,其中62,660例(4.9%)为耳鼻咽喉科性质。味觉障碍、嗅觉丧失、鼻漏、咽喉紧绷感、耳鸣和眩晕等信号比值达到显著水平,而面瘫、贝尔麻痹和过敏反应未达信号阈值。

要点

  • COVID-19疫苗相关耳鼻咽喉科不良事件占全部不良事件的4.9%。
  • 味觉障碍、嗅觉丧失、鼻漏、咽喉不适、耳鸣和眩晕的信号比值显著。
  • 面瘫、贝尔麻痹和过敏反应未达到信号阈值,无显著意义。

核心结论

  • 尽管报告了多种耳鼻咽喉科症状,但仅少数具有临床显著性。
  • 面瘫、贝尔麻痹和过敏反应未达到判定为显著的信号阈值。

研究设计与样本

  • 回顾性分析国家注册登记数据库(VAERS),查询2020年12月至2021年5月所有COVID-19疫苗接种不良事件。
  • 将投诉分类为耳鼻咽喉科并细分至不同解剖部位,计算报告比值比(ROR)和比例报告比值比(PRR)。

主要发现

  • Moderna、Pfizer-BioNTech和Janssen疫苗报告的不良事件总数为1,280,950例。
  • 其中62,660例(4.9%)为耳鼻咽喉科性质:32.6%与口咽/喉相关,18.3%与鼻腔/鼻窦相关,17.1%与耳/前庭系统相关,10.0%与口腔相关,21.9%为杂项。
  • 信号比值达到显著水平:味觉障碍(n=2124,PRR: 17.33,ROR: 16.36)、味觉丧失(n=1376,PRR: 2.81,ROR: 2.81)、嗅觉丧失(n=983,PRR: 4.01,ROR: 4.01)、鼻漏(n=2203,PRR: 2.99,ROR: 3.00)、咽喉紧绷感(n=3666,PRR: 4.99,ROR: 5.00)、咽喉刺激(n=3313,PRR: 4.51,ROR: 4.52)、吞咽困难(n=2538,PRR: 2.07,ROR: 2.07)、耳鸣(n=4377,PRR: 3.97,ROR: 3.98)、眩晕(n=2887,PRR: 3.93,ROR: 3.93)。
  • 信号比值不显著:面瘫、贝尔麻痹、过敏反应、鼻窦炎、听力障碍和耳痛。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: With widespread vaccination against COVID-19, concerns regarding side effects have been raised. We aim to assess the frequency of otolaryngologic adverse events (AEs) following COVID-19 vaccination as compared with other vaccines in a national database. STUDY DESIGN: Retrospective analysis of national registry. METHODS: The Food and Drug Administration's Vaccine Adverse Event Reporting System (VAERS) database was queried from December 2020 to May 2021 for all COVID-19 vaccination AEs. Complaints were categorized as otolaryngologic and sub stratified into different anatomic components. Reporting odds ratios (ROR) and proportional reporting ratios (PRR) were determined for AEs of clinical significance. RESULTS: The total number of AEs reported from vaccination with the Moderna, Pfizer-BioNTech, and Janssen vaccines equaled 1,280,950. Of these, 62,660 (4.9%) were otolaryngologic in nature, with 32.6% associated with the oropharynx/larynx, 18.3% with the nasal cavity/sinuses, 17.1% with the ears/vestibular system, 10.0% with the oral cavity, and 21.9% miscellaneous. Signal ratios reached significance levels for dysgeusia (n = 2124, PRR: 17.33, ROR: 16.36), ageusia (n = 1376, PRR: 2.81, ROR: 2.81), anosmia (n = 983, PRR: 4.01, ROR: 4.01), rhinorrhea (n = 2203, PRR: 2.99, ROR: 3.00), throat tightness (n = 3666, PRR: 4.99, ROR: 5.00), throat irritation (n = 3313, PRR: 4.51, ROR: 4.52), dysphagia (n = 2538, PRR: 2.07, ROR: 2.07), tinnitus (n = 4377, PRR: 3.97, ROR: 3.98), and vertigo (n = 2887, PRR: 3.93, ROR: 3.93). Signal ratios were not significant for facial paralysis, Bell's palsy, anaphylaxis, sinusitis, hearing disability, and ear pain. CONCLUSIONS: Although several otolaryngologic symptoms were reported, few were found to be clinically significant. Of note, facial paralysis, Bell's palsy, and anaphylaxis did not meet signal thresholds to be determined significant. LEVEL OF EVIDENCE: 4 Laryngoscope, 134:1163-1168, 2024.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Ahsanuddin S, Jin R, Dhanda AK, et al. Otolaryngologic Side Effects After COVID-19 Vaccination. Laryngoscope. 2023. PMID: 37539984. doi:10.1002/lary.30923

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。